Viewpoint: France commissions new glyphosate-cancer study to justify more weed killer regulations

After reading this article, I relay the following comment from the collective Science-Technologies-Action (STA): “At the request of the [French] government, ANSES is launching a call for applications to improve knowledge on the carcinogenicity of glyphosate.”

This is the title of the communiqué published July 19, 2019 by the four ministers of Agriculture, Health, Research and Ecology who had seized ANSES on March 28, 2018,  “given the divergent opinions offered by the agencies that make reference in the field of evaluation.”

[Editor’s note: Albert Amgar is the former president of a French food safety company.]

The results of this study, costing € 1.2 million [$1,333,092], will be available within 18 months and will complete the review dossier for the re-authorization of glyphosate by the European Union in 2022. The STA Collective is asking several questions about this initiative, including: why do we need a new study on glyphosate when this herbicide has been the subject of nearly 50 years of multiple studies, and all French, European and international health agencies have concluded the absence of health risk?

[Editor’s note: This article was written in French. This summary was translated and lightly edited for clarity.]

Read full, original article: Glyphosate: waste of public funds to justify a political decision!

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-10-07-at-1.03.15-PM
Anti-vaxxers’ double whammy: Exaggerated vaccine fears have fueled measles outbreaks and preventable deaths—and left survivors more vulnerable to other infections for years
Crossed-Out-Calendar-with-Milk-Carton
Viewpoint: The shocking consequences after a year of Robert F. Kennedy Jr.'s distortions, deceptions, and flat-out falsehoods
Frosted Blueberries Under Magnification
MAHA moms divided over RFK Jr.’s food‑safety efforts, as recall alerts grow and outbreaks spread
Pride and Patriotism in the Breeze
Retreat from identity labels: Does the sharply declining number of young teens identifying as gay and bisexual reflect an ideological shift?
Screenshot-2026-10-08-at-10.41.33-AM
Viewpoint: Wellness patches: Most vitamin supplements are useless and sometimes even dangerous, but this craze is even worse
Screenshot-2026-10-13-at-10.35.49-AM
Challenging health misinformation? People are more likely to believe AI when it responds with empathy
Golden Wheat Under a Starry Sky
Viewpoint: ‘Bureaucratic and economic obstacles’ to agricultural biotechnology: Europe creeps into the 21st century, but blocks remain
Screenshot-2026-10-12-at-10.44.38-AM
Widely condemned as unethical, hepatitis B vaccine study funded by RFK Jr’s CDC gets a final greenlight
Cross and Syringe Standoff
Viewpoint: Hijacking Jesus: How anti-vaccine fanatics are exploiting religious exemptions and killing children
Screenshot-2026-09-22-at-12.26.15-PM
‘Forever chemical’ concerns: Separating hysteria from reasonable concern in the debate over PFAS danger
Prescription Capsules Scattered on Twenty-Dollar Bills
Facts & Fallacies podcast: America's health care system is broken. A doctor explains how to fix it, Part 2
Deepfake Democracy Media Mosaic
31 states have passed a patchwork of laws to limit election deepfake commercials. They’re not working very well.
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.